Beta Bionics (BBNX) Competitors $15.30 -0.58 (-3.65%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BBNX vs. INSP, PRCT, LQDA, LMAT, AORT, EYE, CNMD, ENOV, NVCR, and SSIIShould you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Liquidia Technologies (LQDA), LeMaitre Vascular (LMAT), Artivion (AORT), National Vision (EYE), CONMED (CNMD), Enovis (ENOV), NovoCure (NVCR), and SS Innovations International (SSII). These companies are all part of the "medical equipment" industry. Beta Bionics vs. Its Competitors Inspire Medical Systems PROCEPT BioRobotics Liquidia Technologies LeMaitre Vascular Artivion National Vision CONMED Enovis NovoCure SS Innovations International Beta Bionics (NASDAQ:BBNX) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk. Is BBNX or INSP more profitable? Inspire Medical Systems has a net margin of 6.17% compared to Beta Bionics' net margin of 0.00%. Inspire Medical Systems' return on equity of 10.38% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Inspire Medical Systems 6.17%10.38%8.93% Do institutionals and insiders believe in BBNX or INSP? 94.9% of Inspire Medical Systems shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer BBNX or INSP? Beta Bionics presently has a consensus target price of $22.56, indicating a potential upside of 47.42%. Inspire Medical Systems has a consensus target price of $165.62, indicating a potential upside of 77.99%. Given Inspire Medical Systems' higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75Inspire Medical Systems 0 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.54 Which has better earnings and valuation, BBNX or INSP? Inspire Medical Systems has higher revenue and earnings than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$65.12M10.21-$54.76MN/AN/AInspire Medical Systems$802.80M3.43$53.51M$1.7353.79 Does the media favor BBNX or INSP? In the previous week, Inspire Medical Systems had 17 more articles in the media than Beta Bionics. MarketBeat recorded 23 mentions for Inspire Medical Systems and 6 mentions for Beta Bionics. Inspire Medical Systems' average media sentiment score of 1.07 beat Beta Bionics' score of 0.70 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 13 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryInspire Medical Systems beats Beta Bionics on 10 of the 13 factors compared between the two stocks. Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBNX vs. The Competition Export to ExcelMetricBeta BionicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$690.31M$7.03B$5.74B$9.66BDividend YieldN/A1.29%4.45%4.07%P/E RatioN/A27.1630.3725.05Price / Sales10.2164.86431.52104.48Price / CashN/A21.6837.0358.50Price / Book2.206.728.946.15Net Income-$54.76M$178.31M$3.26B$265.47M7 Day Performance1.32%-4.05%-0.19%-2.02%1 Month Performance12.58%-2.11%3.83%0.34%1 Year PerformanceN/A8.43%28.77%20.73% Beta Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBNXBeta Bionics2.8068 of 5 stars$15.30-3.7%$22.56+47.4%N/A$690.31M$65.12M0.00294Insider TradeINSPInspire Medical Systems4.9316 of 5 stars$84.68-3.1%$173.31+104.7%-53.6%$2.58B$802.80M48.951,246Positive NewsBuyback AnnouncementShort Interest ↓PRCTPROCEPT BioRobotics3.477 of 5 stars$40.12-0.6%$74.88+86.6%-39.4%$2.25B$224.50M-25.88430LQDALiquidia Technologies3.5019 of 5 stars$26.09+3.5%$30.11+15.4%+176.9%$2.17B$14M-15.3550LMATLeMaitre Vascular1.9175 of 5 stars$95.81+0.7%$98.00+2.3%+11.5%$2.15B$219.86M46.51490AORTArtivion3.3174 of 5 stars$42.96-1.8%$39.80-7.4%+66.7%$2.06B$388.54M-102.291,600Analyst DowngradeInsider TradeEYENational Vision2.7604 of 5 stars$22.95-1.2%$24.73+7.7%+118.8%$1.84B$1.82B-127.5013,411Positive NewsCNMDCONMED4.2927 of 5 stars$52.63-4.6%$59.80+13.6%-20.1%$1.71B$1.31B14.913,900News CoverageENOVEnovis4.3304 of 5 stars$28.88-2.4%$51.00+76.6%-32.1%$1.69B$2.11B-2.037,367NVCRNovoCure4.1623 of 5 stars$11.59-0.3%$28.79+148.4%-33.2%$1.30B$605.22M-7.431,488News CoverageSSIISS Innovations InternationalN/A$6.75+3.8%N/AN/A$1.26B$20.65M0.004Gap Up Related Companies and Tools Related Companies Inspire Medical Systems Competitors PROCEPT BioRobotics Competitors Liquidia Technologies Competitors LeMaitre Vascular Competitors Artivion Competitors National Vision Competitors CONMED Competitors Enovis Competitors NovoCure Competitors SS Innovations International Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBNX) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access